RECOVERY ROOM EARLY WARNING SCORE

June 26, 2025 updated by: İlke Dolgun, Istinye University

A NEW EARLY WARNING SCORE TO SUPPORT CLINICAL DECISION PROCESSES IN POSTANESTHETIC FOLLOW-UP: RECO-EWS

In this study, we aimed to develop a scoring system that facilitates patient risk stratification in the recovery room during the postanesthetic follow-up period and can objectively identify patients in need of early intervention.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

208

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients over 18 years of age, in ASA class I-III, who have undergone planned elective surgery under general anesthesia, and who have been informed and given informed consent in advance of the study.

Description

Inclusion Criteria:

  • Those over 18 years of age,
  • Those in ASA I-III class,
  • Those who have undergone planned elective surgery under general anesthesia,
  • Those who have been informed about the study in advance and given their consent.

Exclusion Criteria:

  • Those under 18 years of age,
  • Those who underwent emergency intervention,
  • Those in the ASA-Ⅳ class,
  • Those who underwent regional anesthesia,
  • Those with a history of cognitive retardation, visual-hearing impairment or psychiatric disease that prevents communication, those who have previously been diagnosed with neurocognitive disorders,
  • Patients who could not complete the procedure, patients with data loss,
  • Patients whose general anesthesia duration is less than 90 minutes will not be included in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
RECO-EWS
Time Frame: 24 HOURS
0-7 low risk, 7-10 medium risk, ≥10 high risk
24 HOURS

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Istinye University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 1, 2025

Primary Completion (Estimated)

November 1, 2025

Study Completion (Estimated)

December 1, 2025

Study Registration Dates

First Submitted

June 26, 2025

First Submitted That Met QC Criteria

June 26, 2025

First Posted (Actual)

July 4, 2025

Study Record Updates

Last Update Posted (Actual)

July 4, 2025

Last Update Submitted That Met QC Criteria

June 26, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • HASEKI AHMET TEZ

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Early Warning Score

Clinical Trials on EARLY WARNING SCORE

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jordan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe